GDF3 and cancer: Having considered the importance of CSC markers identification and their exploitation in targeted cancer therapy, since there is not any evidence reporting the expression of GDF3 in ESCC, the expression of GDF3 in the disease and its correlation with clinicopathological features of the patients were elucidated.